###begin article-title 0
###xml 109 113 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 113 116 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice
###end article-title 0
###begin p 1
###xml 39 72 39 72 <email xmlns:xlink="http://www.w3.org/1999/xlink">andreas.habenicht@mti.uni-jena.de</email>
CORRESPONDENCE Andreas J.R. Habenicht: andreas.habenicht@mti.uni-jena.de
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 613 616 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 609 616 609 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE<sup>&#8722;/&#8722;</sup></italic>
###xml 1160 1164 1154 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 1164 1167 1158 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
###xml 1245 1248 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
Atherosclerosis involves a macrophage-rich inflammation in the aortic intima. It is increasingly recognized that this intimal inflammation is paralleled over time by a distinct inflammatory reaction in adjacent adventitia. Though cross talk between the coordinated inflammatory foci in the intima and the adventitia seems implicit, the mechanism(s) underlying their communication is unclear. Here, using detailed imaging analysis, microarray analyses, laser-capture microdissection, adoptive lymphocyte transfers, and functional blocking studies, we undertook to identify this mechanism. We show that in aged apoE-/- mice, medial smooth muscle cells (SMCs) beneath intimal plaques in abdominal aortae become activated through lymphotoxin beta receptor (LTbetaR) to express the lymphorganogenic chemokines CXCL13 and CCL21. These signals in turn trigger the development of elaborate bona fide adventitial aortic tertiary lymphoid organs (ATLOs) containing functional conduit meshworks, germinal centers within B cell follicles, clusters of plasma cells, high endothelial venules (HEVs) in T cell areas, and a high proportion of T regulatory cells. Treatment of apoE-/- mice with LTbetaR-Ig to interrupt LTbetaR signaling in SMCs strongly reduced HEV abundance, CXCL13, and CCL21 expression, and disrupted the structure and maintenance of ATLOs. Thus, the LTbetaR pathway has a major role in shaping the immunological characteristics and overall integrity of the arterial wall.
###end p 3
###begin p 4
###xml 212 215 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 395 401 <span type="species:ncbi:3818">peanut</span>
Abbreviations used: alpha-LTbetaR, agonistic LTbetaR antibody; AAA, abdominal aorta aneurysm; ATLO, aorta tertiary lymphoid organ; DN, double-negative; FDC, follicular DC; GC, germinal center; GO, gene ontology; HEV, high endothelial venule; LCM, laser-capture microdissection; LTbeta, lymphotoxin beta chain; LTbetaR, LTbeta receptor; MAdCAM-1, mucosal addressin cell adhesion molecule 1; PNA, peanut agglutinin; PNAd, peripheral LN addressin; SLO, secondary lymphoid organ; SMA, smooth muscle actin; TLO, tertiary lymphoid organ; TNFRSF1A, tumor necrosis factor receptor superfamily, member 1A.
###end p 4
###begin p 5
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 859 860 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 952 953 952 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1002 1026 1002 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apolipoprotein-deficient</italic>
###xml 1028 1032 1028 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 1032 1035 1032 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1073 1074 1073 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1765 1767 1765 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 795 803 <span type="species:ncbi:9606">patients</span>
###xml 914 919 <span type="species:ncbi:9606">human</span>
###xml 1037 1041 <span type="species:ncbi:10090">mice</span>
Most studies of atherosclerosis to date have focused on intima lesions, which are composed of lipid-laden macrophage/foam cells, T cells, and smooth muscle cells (SMCs). These lesion-forming cells elicit persistent inflammation and ultimately trigger adaptive immune responses toward arterial wall-derived autoantigens, such as heat shock proteins or oxidized LDL. However, how and where atherosclerosis inflammation is translated into adaptive immune responses, including T and B cell autoimmunity, remains to be fully understood (1-6). It is unlikely that atherosclerotic intimal lesions carry out critical steps of adaptive immune responses themselves. Although such reactions may occur in secondary lymphoid organs (SLOs), infiltrates of leukocytes in the adventitia of coronary arteries in patients afflicted with atherosclerosis were noted decades ago (7), and adventitial B cell follicle-like aggregates in human aortae were recently described (8). We and others reported that the adventitia of apolipoprotein-deficient (apoE-/-) mice contained T/B cell aggregates (9-11). Although these data supported the concept that arterial wall inflammation spreads from the intima to the adventitia, the impact of adventitial immunity on arterial wall biology remains puzzling and unresolved. Moreover, the mechanism of how the inflammation spreads between the intima and the adventitia is unknown. The cellular composition of the two inflammatory foci is distinct, and there is no histological evidence that inflammatory cells readily traverse the medial SMC compartment to mediate steady and ongoing communication between the intima and adventitia. Indeed, passage of lymphocytes and phagocytes through the medial compartment of great arteries is typically minimal (12), rendering the media itself some of the properties of immunoprivileged tissues.
###end p 5
###begin p 6
Here, we have set out to characterize the mechanistic basis of communication between the two compartments, as we have reasoned that meeting the long-term goal of understanding whether the adventitial inflammation has either a beneficial or pathological role in atherosclerosis may require experimental manipulation of the inflammatory response in the adventitia itself. We now report that medial SMCs underlying intimal plaques become activated, and through a lymphotoxin beta receptor (LTbetaR)-dependent signaling pathway, are induced to express CXCL13/CCL21, which in turn drives recruitment of T/B cell aggregates. These aggregates are precursors of fully structured aorta tertiary lymphoid organs (ATLOs) that contain large numbers of regulatory T cells (T reg cells), germinal centers (GCs), high endothelial venules (HEVs), and LN-like conduits that connect ATLOs to the medial SMC compartment and likely sustain and amplify the adventitial response. These data reveal how the intima and adventitia communicate to develop a coordinated reaction, even in an anatomical region where inflammatory cell traffic between the two compartments is limited.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin title 8
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
ATLO neogenesis occurs in old apoE-/- mice and is confined to lesion-burdened abdominal aorta
###end title 8
###begin p 9
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 374 378 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 378 381 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 510 518 498 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 a</xref>
###xml 681 689 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 b</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
We searched for ATLOs in 6-130-wk-old mice (n = 30) using a three-stage classification scheme (Fig. S1, available at ). ATLO neogenesis was initiated at >32 wk and occurred in approximately75% of mice afflicted with abdominal aorta atherosclerosis at 78 wk. We compared ATLO incidence in the innominate artery with the incidence in the abdominal aorta at 78 wk. Most (8/11) apoE-/- mice developed ATLO stage II/III in the abdominal aorta, whereas only 1/11 mice showed a stage I ATLO in the innominate artery (Fig. 1 a). We never observed ATLO formation in aorta segments that were not affected by lesions. Moreover, lesion sizes in the abdominal aorta correlated with ATLO sizes (Fig. 1 b).
###end p 9
###begin p 10
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Incidence of ATLOs in different aorta segments and association of ATLOs and plaques.</bold>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 229 232 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 254 255 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 411 412 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
Incidence of ATLOs in different aorta segments and association of ATLOs and plaques. (a) Preferential occurrence of ATLOs in the abdominal aorta; innominate arteries and abdominal aortae were examined for ATLO stages in aged apoE-/- mice. chi-Square (chi2) test, P < 0.02. (b) ATLO sizes correlate with plaque sizes; morphometry was performed by determination of plaque size/media size or ATLO size/media size (n = 11 mice). Pearson correlation coefficient: 0.783. P < 0.01.
###end p 10
###begin title 11
Characterization of ATLO cellularity and structure
###end title 11
###begin p 12
###xml 191 199 191 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 a</xref>
###xml 246 247 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 a</xref>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 a</xref>
###xml 409 410 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 434 435 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 444 452 438 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 a</xref>
###xml 555 556 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 602 603 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 626 634 620 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 a</xref>
###xml 685 686 679 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 697 705 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 a</xref>
###xml 722 724 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 726 728 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 745 746 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 816 824 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 b</xref>
###xml 883 891 877 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 b</xref>
###xml 979 980 973 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 983 991 977 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 c</xref>
###xml 1026 1027 1020 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1029 1037 1023 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 c</xref>
###xml 1075 1076 1069 1070 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1078 1086 1072 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 c</xref>
###xml 1173 1175 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1276 1284 1270 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 c</xref>
###xml 1365 1373 1359 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 c</xref>
###xml 1528 1529 1522 1523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 571 577 <span type="species:ncbi:3818">peanut</span>
ATLOs were crescent-shaped and contacted the external lamina, wrapping around portions of or the entire aorta. Diameters of some ATLOs exceeded those of the media and the associated lesions (Fig. 2 a, top left). They showed B cell follicles (B220+; Fig. 2 a, top right) containing ectopic GCs that were equipped with follicular DC (FDC) networks (CD35+; Fig. 2 a, middle left), and separate T cell (CD3epsilon+) and plasma cell (CD138+) areas (Fig. 2 a, middle right). GCs in B cell follicles showed signs of activation as indicated by proliferating (Ki67+) centrocytes (peanut agglutinin-positive [PNA+]) in GC B cell areas (Fig. 2 a, bottom left) surrounded by follicular mantle (IgD+) B cells (Fig. 2 a, bottom right) (13, 14). Numerous Foxp3+ regulatory T cells (T reg cells) were observed in ATLO T cell areas (Fig. 2 b, left), similar to T areas of the adjacent paraaortic LN (Fig. 2 b, right). ATLOs were supplied with multiple HEVs (peripheral LN addressin positive [PNAd+]; Fig. 2 c, top left), blood vessels (MECA-32+; Fig. 2 c, top right), and lymph vessels (Lyve1+; Fig. 2 c, top right), indicating extensive neoangiogenesis. Similar to autoimmune thyroiditis (15), ATLO-associated lymph vessels had distended lumina caused by large numbers of intraluminal cells (Fig. 2 c, bottom left, open triangles), whereas lymph vessels adjacent to ATLOs did not (Fig. 2 c, bottom right). Unlike paraaortic LNs (Fig. S2, available at ), ATLOs contacted the external lamina and lacked capsules including rims of peripheral Lyve1+ cells.
###end p 12
###begin p 13
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ATLO cellularity and structure and quantification of leukocyte subsets in abdominal and thoracic aorta segments.</bold>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 379 380 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 405 406 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 459 460 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 488 489 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1137 1138 1130 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1197 1200 1190 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1193 1200 1186 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE<sup>&#8722;/&#8722;</sup></italic>
###xml 1403 1404 1393 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1478 1479 1465 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1496 1497 1483 1484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1519 1520 1503 1504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1524 1525 1508 1509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1528 1529 1512 1513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1659 1660 1640 1641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1663 1664 1644 1645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1667 1668 1648 1649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1701 1702 1682 1683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1707 1708 1688 1689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1807 1808 1786 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 195 200 <span type="species:ncbi:10090">mouse</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
###xml 1816 1820 <span type="species:ncbi:10090">mice</span>
ATLO cellularity and structure and quantification of leukocyte subsets in abdominal and thoracic aorta segments. (a) ATLO position relative to media (dashed lines) and plaque (P) of aged apoE-/- mouse (Oil Red O/hematoxylin); B cell follicle (B220); and T cell area (CD3epsilon). FDCs in GC (CD35, filled arrow), plasma cells (CD138, open arrow), and DAPI (DNA); GCs contain Ki67+ (triangles) cells in PNA+ areas (asterisks) and follicular mantle B cells (IgD+; open triangles). (b) Foxp3+ T reg cells in ATLO T cell area (left, arrows) and in T cell area of paraaortic LN (right). (c) HEVs (PNAd; top left, filled arrows), blood vessels (MECA-32; top and bottom right; filled arrows indicate HEVs, open arrows indicate blood vessels), ATLO lymph vessel (Lyve1; top right and bottom left, open triangles), and normal lymph vessels (top right, filled triangle); asterisk indicates vena cava. Bars: 100 mum. (d) Absolute numbers of lymphocyte subsets per aorta segment (open columns, thoracic aorta; shaded columns, abdominal aorta). CD19, P < 0.0005; CD4, P < 0.05; CD8, n.s.; DN, P < 0.005; Foxp3, P < 0.02; one-sided unpaired Student's t test. (e) Flow cytometric analysis of aortae from old apoE-/- mice. Aortae were separated into similarly sized abdominal and thoracic segments, and single-cell suspensions were analyzed for expression of CD19/TCRbeta (top two plots, lymphocyte gate within the CD45+ population), as well as CD4/CD8 and CD4/Foxp3 (middle four plots, TCRbeta+ gate within CD45+ lymphocytes). TCRbeta+ CD4-CD8- DN T cells from the abdominal aorta were further characterized for CD69/CD28 and CD44/NK1.1 expression (bottom two plots, TCRbeta+CD4-CD8- gate). DN T cells were also CD25+Foxp3- (not depicted). Numbers in quadrants represent percentages of positive cells (mean values +/- SD; n = 7-12 mice).
###end p 13
###begin title 14
Aorta leukocyte lineage composition changes with age and shows marked differences in thoracic versus abdominal aorta
###end title 14
###begin p 15
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 256 259 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 340 343 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 446 450 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 450 453 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 460 462 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 519 523 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 523 526 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 574 575 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 580 581 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 591 592 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 714 718 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 718 721 716 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 807 815 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 d</xref>
###xml 972 983 970 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, a&#8211;c</xref>
###xml 1013 1014 1011 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1035 1043 1033 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 e</xref>
###xml 1140 1141 1138 1139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1143 1151 1141 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 e</xref>
###xml 1265 1266 1263 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1270 1271 1268 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1276 1277 1274 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1283 1284 1281 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1298 1306 1296 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 e</xref>
###xml 1309 1311 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 1348 1349 1346 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1353 1354 1351 1352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1358 1359 1356 1357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1363 1364 1361 1362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1467 1475 1465 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 e</xref>
###xml 1478 1480 1476 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 1482 1484 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 1549 1550 1544 1545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1554 1555 1549 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1559 1560 1554 1555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1564 1565 1559 1560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1571 1572 1566 1567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1577 1578 1572 1573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1583 1584 1578 1579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1589 1590 1584 1585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1596 1597 1591 1592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1603 1604 1598 1599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1606 1614 1601 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 e</xref>
###xml 1712 1714 1707 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
We previously reported that the formation of T/B cell aggregates follows adventitial T cell infiltration, which parallels intima lesion formation (10). Flow cytometry was used to quantify the aorta leukocyte composition of young and aged wild-type and apoE-/- mice. Aorta digests from young (20 wk) and aged (78 wk) wild-type and young apoE-/- mice (20 wk) contained few CD45+ leukocytes, corroborating previous morphometric analyses in </=52 wk apoE-/- mice (10) (unpublished data). In contrast, aorta digests of aged apoE-/- mice yielded markedly increased numbers of CD45+, CD3+, and CD19+ leukocytes (unpublished data). We next quantified lymphocyte subsets in thoracic versus abdominal aorta segments of aged apoE-/- mice. Absolute numbers of each lymphocyte subset, including both T reg cell subsets (Fig. 2 d), was much higher in the abdominal compared with thoracic aorta segments, thus substantiating the immunohistochemical characterization of ATLO cellularity (Fig. 1, a-c). The number of B cells (CD19+) in thoracic aorta (Fig. 2 e, top right) was low, whereas a large percentage of abdominal aorta leukocytes were B cells (CD19+; Fig. 2 e, top left). Similar to paraaortic LNs, the expanded ATLO T cell compartment contained considerable numbers of CD3+/CD4+/CD25+/Foxp3+ T reg cells (Fig. 2 e) (16). Moreover, increased numbers of TCR+/CD3+/CD4-/CD8- double-negative (DN) T cells were found in abdominal aorta segments compared with the thoracic aorta (Fig. 2 e) (17, 18). Interestingly, aortic DN T cells had a marker profile (TCRbeta+/CD3+/CD4-/CD8-/NK1.1-/CD44+/CD25+/CD69+/ CD28+/Foxp3-; Fig. 2 e, bottom) that resembled T reg cells, which were recently shown to suppress alloimmune responses (18).
###end p 15
###begin p 16
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 273 276 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 550 551 550 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 563 564 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 575 576 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 580 581 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 585 586 582 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 590 591 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 597 598 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
Overall, these data indicate that (a) ATLO neogenesis is preferentially located in the abdominal aorta; (b) ATLO neogenesis exclusively occurs in aorta segments afflicted with severe atherosclerosis; (c) ATLO size correlates with plaque size; (d) ATLOs develop in aged apoE-/-, but not aged wild-type, mice; (e) ATLO neogenesis is characterized by marked B cell accumulation at various stages of maturation and accompanied by substantial absolute increases in several lymphocyte subsets; and (f) a considerable percentage of ATLO T cells are CD3+/CD4+/CD25+/Foxp3+ or TCRbeta+/CD3+/CD4-/CD8-/Foxp3- T reg cells.
###end p 16
###begin title 17
ATLOs promote lymphocyte recruitment and recirculation into the arterial wall
###end title 17
###begin p 18
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 175 178 175 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 524 532 524 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 a</xref>
###xml 676 684 676 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 a</xref>
###xml 708 709 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 819 827 819 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 b</xref>
###xml 957 965 957 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 b</xref>
###xml 984 985 984 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1013 1014 1013 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1021 1022 1021 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1029 1037 1029 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 b</xref>
###xml 1077 1078 1077 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1085 1086 1085 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1102 1110 1102 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 b</xref>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
To examine the ability of ATLOs to actively promote lymphocyte recruitment and/or recirculation into the arterial wall, we performed adoptive transfer experiments in aged apoE-/- mice using naive 12-wk-old wild-type splenocytes labeled with CFSE (19). At 3 h after transfer, CFSE+ cells were observed in ATLOs, although more cells were present in regional LNs and spleen (unpublished data). However, at 18 h (when >90% of the transferred cells had left the circulation), ATLOs contained considerable numbers of lymphocytes (Fig. 3 a), whereas none or only few were observed in adjacent adventitia, retroperitoneal paraaortic adipose tissue, media, or atherosclerotic plaques (Fig. 3 a and not depicted). CFSE+ cells were readily detected throughout all ATLO compartments, although most cells localized to T cell areas (Fig. 3 b, left 4 images, arrows). Colocalization studies of CFSE with CD3 and B220 indicated a preference of recruited cells for T cells (Fig. 3 b, Merge). Many CFSE+ cells colocalized with PNAd+/Meca32+ HEVs (Fig. 3 b; right open arrows), but none with PNAd-/Meca32+ blood vessels (Fig. 3 b, right asterisks; Fig. S3 and Video 1, available at ). Thus, ATLOs promote high rates of T cell recruitment into the arterial wall on an ongoing basis from the bloodstream, most likely through HEVs.
###end p 18
###begin p 19
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ATLOs promote lymphocyte recruitment and recirculation into the arterial wall</bold>
###xml 372 373 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 641 642 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 787 788 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 828 829 828 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 833 834 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 901 902 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 906 907 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
ATLOs promote lymphocyte recruitment and recirculation into the arterial wall. CFSE labeling and i.v. application of splenocytes was performed as described in Materials and methods. 18 h later, aorta was prepared and consecutive sections were examined. (a) Overview of abdominal aorta segment with adjacent intima lesion and ATLO at 18 h reveals selective presence of CFSE+ splenocytes in ATLO, but none in adjacent adventitia, media, or plaque (filled arrow). Unspecific autofluorescence was subtracted from the specific CFSE-related fluorescence as described in Materials and methods. L, lumen; A, adventitia; M, media; P, plaque. (b) CFSE+ splenocytes preferentially accumulate in ATLO T cell area (left images, filled arrows) when compared with B cell follicles (open diamonds); CFSE+ cells are associated with HEVs (MECA-32+PNAd+ structure, open arrows), but not with blood vessel lumina (MECA-32+PNAd- structures, asterisks; Video 1, available at ). Bars, 20 mum.
###end p 19
###begin title 20
Lesion and ATLO genes signify separable immune responses
###end title 20
###begin p 21
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 630 634 630 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATLO</italic>
###xml 644 652 644 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 738 746 738 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 843 851 843 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 1151 1159 1151 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 1347 1353 1347 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 1355 1360 1355 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccl21</italic>
###xml 1366 1369 1366 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltb</italic>
###xml 1371 1379 1371 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 401 406 <span type="species:ncbi:10090">mouse</span>
Because lesion gene expression should become detectable at 32 wk (10) and ATLO gene expression may follow at 78 wk (see above), aorta gene expression microarrays from 6-, 32-, and 78-wk-old mice were prepared following MIAME guidelines (; data were deposited in National Center for Biotechnology Information's gene expression omnibus, GEO accession no. ). Differentially up-regulated genes in apoE-/- mouse aortae were identified (Table S1, available at ). A fuzzy c-means cluster algorithm defined two clusters differing in their onset of gene up-regulation (Fig. S4): an early (32 wk) atherosclerosis cluster and a late (78 wk) ATLO cluster (Fig. 4 a). Genes up-regulated at 32 wk largely mirrored the influx of monocytes into lesions (Fig. 4 a and Table S1), whereas genes up-regulated at 78 wk mirrored TLO neogenesis and B cell immunity (Fig. 4 a and Table S1). Gene ontology (GO) terms cytokine activity, cytokine binding, and immunoglobulin binding in the atherosclerosis cluster and cytokine activity, chemokine receptor activity, and antigen binding in the ATLO cluster exemplified the differentially expressed genes in plaques versus ATLOs (Fig. 4 a). The ATLO cluster contained the following genes not previously associated with atherosclerosis: genes regulating B cell recruitment/maturation, GC formation, and autoimmunity, including Cxcl13, Ccl21, and Ltb (Fig. 4 a). Thus, genes of the atherosclerosis and ATLO clusters selectively emerged in the diseased aorta in a statistically significant stepwise fashion. Selected transcripts were confirmed by quantitative RT-PCR (Fig. S5).
###end p 21
###begin p 22
###xml 62 89 62 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atherosclerosis versus ATLO</italic>
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lifespan aorta gene expression profiling identifies candidate <italic>atherosclerosis versus ATLO</italic> genes.</bold>
###xml 582 583 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATLO</italic>
###xml 813 830 813 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cytokine activity</italic>
###xml 969 970 969 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1035 1036 1035 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1074 1075 1074 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1212 1219 1212 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
###xml 1224 1229 1224 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccl21</italic>
###xml 1495 1502 1495 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
###xml 1506 1511 1506 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccl21</italic>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1425 1428 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
Lifespan aorta gene expression profiling identifies candidate atherosclerosis versus ATLO genes. Microarrays were prepared from total aortae of individual mice of each genotype (total aorta in a) or from LCM-derived tissues (separated aorta laminae in b). Differentially regulated probe sets were identified as described in Materials and methods. Probe sets specifying genes with the highest signal strengths are displayed. (a) Atherosclerosis cluster displays genes up-regulated between 6 and 32 wk; heat maps at right indicate significantly up-regulated genes (unpaired Student's t test; P < 0.05) of GO terms cytokine activity, cytokine binding, and immunoglobulin binding. ATLO cluster displays genes up-regulated between 32 and 78 wk; heat maps at right indicate significantly up-regulated genes of GO terms cytokine activity, CXC chemokine receptor activity, and antigen binding, (b) Heat maps display LCM preparations of adventitia without plaque or ATLO (left; n = 4 mice), ATLOs (adventitia adjacent to intima plaque; middle; n = 4 mice), or intima plaques (right; n = 3 mice). GO terms for cytokine activity, cytokine binding, antigen processing and presentation, and LN development were examined. (c) Glycam1 and Ccl21 mRNA in situ hybridization analyses of ATLO-burdened abdominal aorta segments. Sense and antisense cRNA probes were generated, and in situ hybridization analyses were performed (filled triangle, HEV; asterisk, lymph vessel). Media and lesions did not show specific Glycam1 or Ccl21 mRNA signals. Broken lines designate media. Bars, 100 mum.
###end p 22
###begin title 23
Laser capture microdissection (LCM) microarrays reveal differential gene expression in ATLOs versus plaques
###end title 23
###begin p 24
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 562 565 562 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 572 580 572 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 b</xref>
###xml 725 731 725 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 733 738 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccl21</italic>
###xml 744 747 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltb</italic>
###xml 749 757 749 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 b</xref>
###xml 822 830 822 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 b</xref>
###xml 916 923 916 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
###xml 1008 1013 1008 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccl21</italic>
###xml 1157 1164 1157 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
###xml 1192 1200 1192 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 c</xref>
###xml 1255 1260 1255 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccl21</italic>
###xml 1313 1321 1313 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 c</xref>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 950 953 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
The stark differences in the overall gene expression patterns between apoE-/- aortae at 32w versus 78w likely reflected the emergence, and dominance, of genes expressed in the ATLOs. To verify this possibility, we selected areas of the abdominal aorta with advanced plaques and separated plaques and corresponding ATLOs by LCM. Adventitia of aorta segments that were not associated with atherosclerosis and adventitia of wild-type mice served as controls. Wild-type adventitia (10) microarrays showed gene signatures that resembled plaque-free adventitia of apoE-/- mice (Fig. 4 b; Supplementary Table S2). Adventitia in aorta segments with associated ATLOs contained numerous genes known to regulate TLO formation including Cxcl13, Ccl21, and Ltb (Fig. 4 b). In contrast, plaques showed prototypic atherosclerosis genes (Fig. 4 b). Genes induced in the adventitia during ATLO neogenesis but absent from plaques are Glycam1 (exclusively expressed by HEV endothelial cells involved in T cell recruitment) and Ccl21 (a T cell chemokine). In situ hybridization combined with immunohistochemical analyses of parallel thin sections (data not shown) demonstrated Glycam1 mRNA signals in ATLO HEVs (Fig. 4 c) but none in media or plaques. Similarly, we observed Ccl21 mRNA signals in HEVs and adventitial lymph vessels (Fig. 4 c). When taken together, these data establish topographical large-scale transcriptome maps for ATLOs versus adjacent lesions proper and reveal a marked dichotomy in adventitial and lesion immune response-regulating genes in diseased aortae.
###end p 24
###begin title 25
LN-like conduits connect media SMCs to ATLOs and transport low molecular weight molecules
###end title 25
###begin p 26
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 774 782 774 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 a</xref>
###xml 907 908 907 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 916 924 916 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 a</xref>
###xml 1467 1475 1441 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 a</xref>
###xml 1782 1790 1756 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 b</xref>
Although gene expression patterns were distinct between the adventitia and plaques, the dependence of ATLOs on intimal lesion development suggested that the compartments communicate. Antigen reaches LNs via migration of antigen-loaded DCs or via directed diffusion through a specialized conduit system that connects afferent lymph vessels and HEVs (20-22). Conduits have not previously been studied in TLOs (23). Owing to their size, conduits cannot transport cells but form a reticular meshwork of fibers consisting of a rodlike core of collagen I wrapped by extracellular matrix sheaths enfolded by podoplanin-expressing fibroblastic reticular cells. Staining with ER-TR7 (unknown antigen) and 8.1.1 (podoplanin/gp38) revealed a reticular meshwork of cordlike structures (Fig. 5 a) in ATLOs. ER-TR7/8.1.1/DAPI staining confirmed colocalization of 8.1.1 with fibroblastic reticular cells adjacent to ER-TR7+ cords (Fig. 5 a, top). ATLO conduits were further identified by their small diameter (conduits, approximately2 mum; capillaries, approximately4 mum), the absence of MECA-32 staining, and the presence of a collagen I core (unpublished data). Because conduits near the adventitia-media border appeared denser, we examined whether they extend into the media. 3D reconstruction of high resolution laser scanning microscopy of stage III ATLOs revealed that ATLO conduits extended into the media gaining access to HEVs of ATLO T areas and other ATLO compartments (Fig. 5 a, bottom left; Fig. S6; Fig. S7 and Video 2; and Fig. S8 and Video 3, available at ). To explore the functionality of ATLO conduits in vivo we used fluorescent dextran particles. After i.v. application, 10 kD dextran, but not 500 kD dextran, particles were taken up by ATLO conduits similar to LN conduits (Fig. 5 b and not depicted). Thus, ATLO conduits resemble LN conduits in size, marker expression, and transport function and establish newly formed structures connecting the adventitia to the media.
###end p 26
###begin p 27
###xml 0 117 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ATLO conduits connect media SMCs with ATLO compartments and facilitate transport of small molecular weight molecules.</bold>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 761 764 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
ATLO conduits connect media SMCs with ATLO compartments and facilitate transport of small molecular weight molecules. (a) Conduits connect the media (M) with HEVs. ECM meshwork (ER-TR7; top left, open arrows) associated with (top left, asterisk) and enfolded by 8.1.1+ fibroblastic reticular cells (top right, filled arrows). Conduit pseudolumen (inset, top right). Conduits at the ATLO periphery (ER-TR7) connect the media with HEVs (bottom panels, arrow; Fig. S4 and Video 2; Fig. S5 and Video 3). (b) ATLO conduits transport low molecular weight molecules. 10 or 500 kD fluorescent dextran was injected i.v.; 15 min later, ATLOs were prepared as described in Materials and methods. Dotted lines indicate ATLO/media border. Note presence of 500 kD dextran in HEV (bottom right) and presence of 10 kD, but not 500 kD, dextran in media. Bars, 50 mum.
###end p 27
###begin title 28
Media SMCs sandwiched between lesions and ATLOs are activated and express CXCL13 and CCL21
###end title 28
###begin p 29
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 279 287 279 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 a</xref>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 357 365 357 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 a</xref>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 416 419 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 546 549 546 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dim</sup>
###xml 554 555 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 624 627 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dim</sup>
###xml 687 695 687 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 b</xref>
###xml 772 773 772 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 783 784 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 806 814 806 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 b</xref>
###xml 929 930 929 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 932 940 932 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 a</xref>
###xml 952 953 952 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 990 991 990 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
Because embryonic SLO formation requires CXCL13 and CCL21 chemokines (24-26), and ectopic expression of CXCL13 is sufficient to induce TLOs (27), we searched for CXCL13/CCL21 in ATLOs. Surprisingly, media segments sandwiched between lesions and ATLOs expressed CXCL13 and CCL21 (Fig. 6 a, top). In contrast, the media of the thoracic aorta of apoE-/- mice (Fig. 6 a, bottom), the media of the abdominal aorta of apoE-/- mice without adjacent lesions, and the media of the entire aorta of wild-type mice (not depicted) were CXCL13-CCL21- or CXCL13dimCCL21-. CXCL13 and CCL21 colocalized with smooth muscle actin (SMA) and SMAdim myofibroblasts, which may represent dedifferentiated SMCs (Fig. 6 b, top). Both CXCL13 and CCL21 colocalized with VCAM-1, indicating that CXCL13+ and CCL21+ SMCs were activated (Fig. 6 b, bottom). In addition to media SMCs, fibroblast-like cells with DC morphology in ATLO B cell follicles were CXCL13+ (Fig. 6 a), and Lyve1+ lymph vessels (L) and larger MECA-32+ blood vessels (arrows) in ATLO T cell areas expressed CCL21. Thus, the media separating plaques and ATLOs becomes modified, containing activated SMCs that express the lymphorganogenic chemokines CXCL13 and CCL21. This activation may be an organizing event by which SMCs support the development and maintenance of ATLOs.
###end p 29
###begin p 30
###xml 0 123 0 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Media SMCs sandwiched between lesions and ATLOs are activated and express the lymphorganogenic chemokines CXCL13 and CCL21.</bold>
###xml 618 619 618 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Media SMCs sandwiched between lesions and ATLOs are activated and express the lymphorganogenic chemokines CXCL13 and CCL21. (a) CXCL13 and CCL21 of ATLO-burdened aorta segment (top). Media SMCs and cells with DC morphology stain positive for CXCL13 in B cell follicle (top left, open triangles) and for CCL21 in T cell area (top right, filled arrows), whereas SMCs of aorta segments without adjacent ATLO (thoracic aorta with plaque) do not (bottom). Medium-sized ATLO blood vessels stain positive for CCL21 (top right, filled arrows), whereas small blood vessels (top right, open arrows) in B cell follicles are CCL21-. L, lymph vessel; P, plaque. (b) Colocalization of SMA and CXCL13 and SMA and CCL21 with VCAM-1 in abdominal aorta segments adjacent to ATLO. Bars, 100 mum.
###end p 30
###begin title 31
SMCs transduce ATLO neogenesis signals through LTbetaR signaling
###end title 31
###begin p 32
###xml 82 84 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 86 88 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 90 92 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 93 95 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 133 137 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfr</italic>
###xml 239 257 236 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vascular SMA &#945;</italic>
###xml 259 264 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Acta2</italic>
###xml 346 366 339 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myelin basic protein</italic>
###xml 368 371 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mbp</italic>
###xml 379 387 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 a</xref>
###xml 403 407 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltbr</italic>
###xml 412 476 405 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tumor necrosis factor receptor superfamily, member 1A (Tnfrsf1a)</italic>
###xml 533 541 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 a</xref>
###xml 588 592 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltbr</italic>
###xml 597 605 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf1a</italic>
###xml 626 630 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfr</italic>
###xml 728 732 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltbr</italic>
###xml 733 741 724 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf1a</italic>
###xml 763 767 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltbr</italic>
###xml 768 776 759 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf1a</italic>
###xml 799 803 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfr</italic>
###xml 850 858 841 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 b</xref>
###xml 903 911 894 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 c</xref>
###xml 1458 1460 1407 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1515 1521 1457 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 1669 1675 1611 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 1700 1708 1642 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 d</xref>
###xml 1869 1871 1804 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 1926 1932 1861 1867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 1939 1947 1874 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 d</xref>
As LTbetaR signaling is required for SLO and TLO formation and CXCL13 expression (15, 23, 28-36), we determined mRNA levels of major Tnfr family members in SMCs. Microarrays of LCM-separated media showed a five- to sevenfold enrichment of vascular SMA alpha (Acta2), and other media marker genes and microarrays of adventitia showed an excess of myelin basic protein (mbp) mRNA (Fig. 7 a and Table S3). Ltbr and tumor necrosis factor receptor superfamily, member 1A (Tnfrsf1a) mRNAs were also strongly expressed in LCM media arrays (Fig. 7 a, Table S3, and not depicted), suggesting that Ltbr and Tnfrsf1a mRNAs are the major Tnfrs expressed by SMCs in vivo. To confirm these findings, we purified SMCs to >/=99% and determined Ltbr/Tnfrsf1a mRNA levels. Indeed, Ltbr/Tnfrsf1a represented the major Tnfr family members in highly purified aorta SMCs (Fig. 7 b), and SMC cultures maintained this pattern (Fig. 7 c). LTbetaR- and TNFRSF1A-dependent signaling pathways were examined in SMCs after addition of agonistic anti-LTbetaR antibody (alpha-LTbetaR) or TNF, respectively; alpha-LTbetaR, but not TNF, activated the alternative NF-kappaB pathway, as indicated by p100 to p52 processing and increased RelB DNA binding; TNF, but not alpha-LTbetaR, increased p100 protein levels, triggered IkappaBalpha degradation, and induced classical RelA DNA binding (unpublished data). Because there is significant cross talk between LTbetaR and TNFRSF1A in fibroblasts (37), we explored whether alpha-LTbetaR and TNF activated Cxcl13 expression in SMCs. qRT-PCR analysis revealed small effects when each agonist was added alone, but a marked synergistic action of both agonists on Cxcl13 mRNA induction at 24 h (Fig. 7 d). Thus, SMCs express LTbetaR and TNFRSF1A as their major TNFR members in vivo, engage the alternative and classical NF-kappaB signaling pathways, respectively (38), and their combined activation strongly up-regulates Cxcl13 mRNA (Fig. 7 d) and protein (unpublished data) in SMCs.
###end p 32
###begin p 33
###xml 0 57 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SMCs express LT&#946;R and TNFRSF1A and induce CXCL13 mRNA.</bold>
###xml 221 226 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Acta2</italic>
###xml 228 231 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mbp</italic>
###xml 237 241 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltbr</italic>
###xml 375 376 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 425 429 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltbr</italic>
###xml 431 439 426 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf14</italic>
###xml 441 449 436 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf1a</italic>
###xml 455 463 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf1b</italic>
###xml 693 699 678 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 839 840 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
SMCs express LTbetaR and TNFRSF1A and induce CXCL13 mRNA. (a) Microarray analyses of LCM-derived media (shaded columns) versus adventitia (open columns) from 78-wk-old wild-type mice were examined for signal strengths of Acta2, Mbp, and Ltbr. Means of three independent LCM preparations of individual aortae +/- SEM. *, P < 0.05; **, P < 0.001; two-sided, unpaired Student's t test. (b) qRT-PCR analysis of the expression of Ltbr, Tnfrsf14, Tnfrsf1a, and Tnfrsf1b expression in freshly isolated SMCs. Means of three independent SMC cultures +/- SEM. (c) Same analyses as in b in cultured SMCs. (d) Cultured SMCs were stimulated with 10 mug/ml alpha-LTbetaR, 1 ng/ml TNF, or both for 24 h, and Cxcl13 transcripts were determined by qRT-PCR. Data represent means of five independent experiments +/- SEM. P < 0.05, one-sided paired Student's t test.
###end p 33
###begin title 34
Ongoing LTbetaR signaling is required to maintain ATLO size and structure
###end title 34
###begin p 35
###xml 15 16 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 20 21 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 71 73 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 74 76 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 78 80 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 82 84 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 86 88 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 90 92 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 94 96 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 126 130 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 130 133 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 313 321 300 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 a</xref>
###xml 376 378 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 508 509 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 550 551 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 576 577 557 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 627 628 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 646 650 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 650 653 631 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 663 671 644 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 a</xref>
###xml 881 889 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 b</xref>
###xml 922 923 900 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 936 944 914 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 c</xref>
###xml 979 985 957 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 987 994 965 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
###xml 1000 1004 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il7r</italic>
###xml 1012 1020 990 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 d</xref>
###xml 1074 1082 1052 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 e</xref>
###xml 1145 1149 1120 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ldlr</italic>
###xml 1149 1152 1124 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1159 1161 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 1249 1253 1224 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 1253 1256 1228 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1340 1344 1312 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 1344 1347 1316 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 913 916 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 1153 1157 <span type="species:ncbi:10090">mice</span>
###xml 1257 1261 <span type="species:ncbi:10090">mice</span>
###xml 1348 1352 <span type="species:ncbi:10090">mice</span>
Ectopic LTalpha1beta2 or CXCL13 is sufficient to induce TLO formation (27-29, 31, 32, 34, 39, 40). Thus, we treated 75-wk-old apoE-/- mice with an antagonistic LTbetaR-Ig for 3 wk to assess its effect on ATLOs. As a positive control for LTbetaR-Ig efficacy, we confirmed that the microarchitecture of the spleen (Fig. 8 a, top), whose structural integrity depends on LTbetaR (39), was disturbed. After 3 wk, LTbetaR-Ig had disrupted marginal zone mucosal addressin cell adhesion molecule 1-positive (MAdCAM-1+) structures and eradicated GC FDCs (CD35+) and GC centrocytes (PNA+), and, to a lesser degree, follicular mantle (IgD+) B cells in aged apoE-/- spleens (Fig. 8 a, bottom). LTbetaR-Ig treatment also markedly disrupted ATLO structure, as shown by a large reduction of B follicle cellularity with minor effects on T cells and plasma cells, a major decrement of ATLO stages (Fig. 8 b), a strong decrease in HEV (PNAd+) incidence (Fig. 8 c), significant reductions of aorta Cxcl13, Glycam1, and Il7r mRNAs (Fig. 8 d), and a moderate attenuation of CXCL13 serum levels (Fig. 8 e). Although LTbetaR-Ig attenuates plasma cholesterol levels in Ldlr-/- mice (41), no effect was observed on total cholesterol or on VLDL-, LDL-, or HDL-cholesterol in apoE-/- mice (Fig. S9 and Table S4, available at ). Thus, antagonism of LTbetaR pathway in apoE-/- mice suppresses ATLO maintenance and structure without affecting plasma lipids.
###end p 35
###begin p 36
###xml 83 89 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 94 101 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
###xml 0 144 0 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In vivo blockade of LT&#946;R by soluble LT&#946;R-Ig disrupts ATLO structure, reduces <italic>Cxcl13</italic> and <italic>Glycam1</italic> mRNAs, and attenuates serum CXCL13 levels.</bold>
###xml 144 148 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ApoE</italic>
###xml 148 151 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 215 216 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 263 264 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 599 600 586 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 746 747 725 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 778 779 757 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 816 817 793 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 952 953 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 983 984 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1024 1030 995 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 1043 1050 1014 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
###xml 1067 1071 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il7r</italic>
###xml 1109 1110 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1188 1189 1157 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1223 1224 1189 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 252 257 <span type="species:ncbi:9606">human</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
In vivo blockade of LTbetaR by soluble LTbetaR-Ig disrupts ATLO structure, reduces Cxcl13 and Glycam1 mRNAs, and attenuates serum CXCL13 levels.ApoE-/- mice at 75 wk were treated three times with 75 mug LTbetaR-Ig (n = 11) or the same concentration of human IgG (n = 6) i.p. every 7 d for 3 consecutive weeks. (a) At the end of the treatment period, LTbetaR-Ig treatment was monitored in the spleen by loss of integrity of marginal zones (MAdCAM-1), FDCs (CD35), cell proliferation (Ki67), centrocytes (PNA), and follicular mantle B cells (IgD); note loss of FDCs and centrocytes and that mantle IgD+ B cells are less affected. (b) ATLO stages were determined after staining with CD3epsilon (T cells), B220 (B cells), and CD35 antisera (FDC). chi2 test, P < 0.05. (c) HEVs (PNAd+) abundance was determined by the chi2 test in LTbetaR-Ig versus control IgG-treated mice (P < 0.05); representative stainings are shown at left. (d) Aortae of LTbetaR-Ig- (n = 6) or control IgG-treated (n = 3) mice were examined by qRT-PCR for Cxcl13 (P < 0.01), Glycam1 (P < 0.05), and Il7r (P < 0.05) mRNAs; unpaired Student's t test; means +/- SEM. (e) serum CXCL13 levels of control hu-IgG-treated mice (n = 4) or LTbetaR-Ig-treated mice (n = 7). Means +/- SEM (P < 0.01). Bars, 100 mum.
###end p 36
###begin title 37
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Intima/media and ATLO/media border regions are infiltrated by CD68+CD11c+ monocytes/macrophages and T cells and show elastic fiber erosion
###end title 37
###begin p 38
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 a</xref>
###xml 516 524 516 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 b</xref>
###xml 731 739 731 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 b</xref>
###xml 109 115 <span type="species:ncbi:9606">humans</span>
Finally, we wondered whether ATLO formation affected the integrity of the aorta, as it has been suggested in humans where B cells within the adventitia of abdominal aortae characterize specimens with aneurysm (42-44). Indeed, ATLOs were associated with leukocyte infiltration, including CD68+ cells, of the abdominal aorta in both the outer and inner media layers (Fig. 9 a, left). Elastin staining indicated erosion of the internal lamina and adjacent elastic membranes in association with atherosclerotic plaques (Fig. 9 b, left arrows). In comparison to thoracic aorta, destruction of abdominal aorta media structure was more pronounced (unpublished data). Erosion of the external lamina was observed in association with ATLOs (Fig. 9 b, right arrows).
###end p 38
###begin p 39
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Thoracic and abdominal aorta media of aged <italic>apoE</italic><sup>&#8722;/&#8722;</sup> aorta is infiltrated by leukocytes and shows differential loss of integrity.</bold>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 199 200 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 703 706 703 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltb</italic>
###xml 753 754 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Thoracic and abdominal aorta media of aged apoE-/- aorta is infiltrated by leukocytes and shows differential loss of integrity. (a) ATLO staining for CD68+ macrophages (left, filled arrows) and CD11c+ macrophages/DCs (right, open arrows) show leukocyte infiltration of inner and outer media. (b) Elastin staining of ATLO-free diseased abdominal aorta shows loss of elastic fiber integrity in the inner media (left arrows), whereas ATLO-associated abdominal aorta shows loss of integrity in inner and outer media (right arrows). Foam cells adjacent to media are often associated with elastin strand breaks (asterisks). (c) FACS-sorted blood monocyte subset (left) microarrays (right) reveal differential Ltb mRNA expression (two-sided unpaired Student's t test; P < 0.0001). Bars, 100 mum.
###end p 39
###begin p 40
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 a</xref>
###xml 155 157 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltb</italic>
###xml 443 454 443 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VE-cadherin</italic>
###xml 600 601 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 664 672 664 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 a</xref>
###xml 682 683 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 808 811 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltb</italic>
###xml 858 860 858 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 872 880 872 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 c</xref>
In addition to CD68, many, but not all, of the infiltrated medial leukocytes were positive for CD11c (Fig. 9 a, right). CD11c expression characterizes Ly6Clo monocytes in blood and of many macrophages in atherosclerotic lesions, but the immediate precursor and functional impact of the CD11c+ or CD11c- myeloid cells in lesions and in the media remain to be determined (45). We observed high expression levels of CD11c, CD68, and Ltb, but not VE-cadherin, mRNAs in LCM media arrays of abdominal aorta that were associated with ATLOs. These data are consistent with immunofluorescent analyses of CD11c+ myeloid cells in the inner and outer media of diseased aorta (Fig. 9 a). MECA-32+ vasa vasora were observed in advanced plaques (which was, however, a rare event), but not in media with associated plaques. Ltb mRNA was highly expressed in sorted blood Ly6Clo monocytes (Fig. 9 c), raising the possibility that the infiltration of this cell type in media may activate SMC LTbetaR to initiate the formation of ATLOs, which in turn promote elastin erosion that may contribute to aneurysm formation. This possibility, and the mechanism by which SMC LTbetaR activation occurs, requires in depth testing in future studies.
###end p 40
###begin title 41
DISCUSSION
###end title 41
###begin p 42
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
The structured assembly of lymphocytes in SLOs is a powerful means to amplify immune surveillance (46). SLOs arise during development at predetermined locations, whereas TLOs emerge in adults at diverse sites in response to persistent inflammation, such as in autoimmunity (23, 25, 33, 35, 36, 47-52). Unlike SLOs, TLOs are often accompanied by tissue destruction with progressing clinical symptoms (30, 36, 53-55). Although common forms of atherosclerosis, including coronary heart disease, are recognized chronic inflammatory diseases (1-6), this work is the first to characterize ATLOs associated with this disease in detail. These data in particular provide mechanistic insight into how, where, and when ATLOs form, and our findings also offer insight into possible roles that ATLOs may have in atherosclerosis.
###end p 42
###begin p 43
###xml 507 509 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 808 810 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1023 1025 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 1027 1029 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1031 1033 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
Concerning the mechanisms of ATLO neogenesis, our findings suggest the new concept that medial SMCs translate signals from the overlying atherosclerotic plaques to promote ATLO neogenesis. We show that SMCs beneath atherosclerotic plaques become activated through LTbetaR and TNFRSF1A signaling to express CXCL13 and CCL21. Indeed, these activated SMCs acquired prototypical features of mesenchymal cells termed lymphoid tissue organizers that were originally described to control embryonic LN development (47). It is well established that certain stromal cells resembling myofibroblasts may differentiate into lymphoid tissue organizers in adult organisms. These lymphoid tissue organizers interact with hyperactivated lymphocytes that are attracted to inflamed tissues and thereby organize TLO neogenesis (25). It is also known that lymphoid tissue organizers can acquire different phenotypes, as seen with activated intestinal fibroblasts in inflammatory bowel disease or activated synoviocytes in rheumatoid arthritis (23, 25, 35). Our findings suggest that SMCs in the aorta adjacent to ATLOs become lymphoid tissue organizers.
###end p 43
###begin p 44
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 629 636 629 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 1054 1056 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1057 1059 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
The lymphoid organization that they bring about is profound, as the level of cellular and structural organization in ATLOs was akin to organization previously only observed in LNs and spleen. ATLOs harboured all hematopoietic and nonhematopoietic cell lineages, cell subtypes, and structures that are required to support lymphocyte recruitment and recirculation and to conduct antigen-dependent (auto)immune responses (4-6, 51, 55, 56). These included FDCs, proliferative B cells that were differentiated and organized in follicles, T/B cell interactions in separate T cell areas, two major T reg cell subsets, and plasma cells (Fig. 10). In addition, newly formed conduits establish an elaborate network connecting ATLOs to the medial SMC. This conduit network likely further facilitates and amplifies ongoing communication between ATLOs and the medial SMCs, and possibly overlying plaque, as these conduits could serve as channels for both soluble antigen and transport of molecules (e.g., chemokines, cytokines) between the activated media and ATLOs (20-22). Our findings show that intravenously infused low molecular weight tracers could access and move through the conduits, highlighting their functionality, though the vector of molecular diffusion could not be determined.
###end p 44
###begin p 45
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Schematic choreography of cells and molecules in ATLO neogenesis.</bold>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 851 854 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
Schematic choreography of cells and molecules in ATLO neogenesis. Blood monocytes/macrophages/foam cells, T cells, and SMCs form atherosclerotic lesions in the intima and initiate a transmural arterial wall inflammation pathway. Lesion cells such as CD11c+ and/or CD11c- myeloid cells and T cells produce TNFR agonists LTbeta and TNF and, after LTbetaR/TNFRSF1A activation and induction of alternative and classical NF-kappaB signaling pathways, media SMCs are activated and acquire features of lymphoid tissue organizers. Lymphorganogenic CXCL13/CCL21 and other mediators gain access to cells residing in the adventitia, recruit B and T cells through vasa vasora, and promote lymphocyte and stromal cell activation. A tissue microenvironment is then generated that induces conduit neogenesis via stimulation of reticular fibroblasts, DC recruitment, HEV formation, ectopic lymph vessel, and blood vessel neogenesis. ATLO formation accelerates and lymphocyte recirculation is markedly facilitated, B cell follicles form, and T reg cells in T cell areas are recruited. Transmural inflammation also generates autoantigen(s), although their nature, transport routes, and functional roles all remain to be defined. Accelerated B cell recruitment leads to B cell follicle formation, and ectopic GCs are activated. Autoantigen-binding FDCs initiates B cell proliferation, differentiation, and affinity maturation. Memory cells and/or plasma cells, and possibly autoreactive T/B cells, together with T reg cell deficiency may lead to clinically apparent and overt autoimmunity and arterial wall pathology.
###end p 45
###begin p 46
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 714 718 714 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 718 721 718 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 243 249 <span type="species:ncbi:9606">humans</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 805 810 <span type="species:ncbi:9606">human</span>
An important observation in our analysis was the restriction of ATLOs to the abdominal aortae of aged apoE-/- mice. Interestingly, it is the area of ATLO formation where abdominal aorta aneurysms (AAAs) preferentially form in mice (9, 10) and humans (8, 42, 43), raising the possibility that ATLOs are linked in some way to AAA. Leukocyte infiltrates have been associated with AAA, but the importance of T or B cells is still controversial (42, 57-59). Because we observed elastic fiber erosion adjacent to ATLO-associated media, we speculate that B cell and/or T cell aggregates in the adventitia of abdominal aortae may contribute to atherosclerosis and AAA pathology. In this context, our findings suggest that apoE-/- mice may serve as a suitable animal model that recapitulates similar events in the human abdominal aorta.
###end p 46
###begin p 47
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 726 727 726 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 384 389 <span type="species:ncbi:9606">human</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
Though B cell follicles were prominent in the adventitia of aged apoE-/- mice, we did not find a high rate of B cell trafficking into the adventitia after adoptive transfer of splenic B cells. It is possible that B cells in the adventitia may expand locally in response to aortic wall antigens. The ongoing GC reactions in ATLOs support this possibility, and from the limited work in human coronary arteries, we anticipate that the range of B cell clones in the adventitia may be broad (43). Nonetheless, ATLO GC reactions may control antigen-dependent affinity maturation similar to the TLO GC B cell progeny of rheumatoid arthritis patients (13, 14, 23, 50, 52, 60). Although innate B cells appear to be atheroprotective (1-6), it remains possible that autoreactive B cells (61) may be generated during later stages of the disease and contribute to plaque growth and/or AAA pathology.
###end p 47
###begin p 48
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1284 1288 1284 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 1288 1291 1288 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1292 1296 <span type="species:ncbi:10090">mice</span>
###xml 1329 1332 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
With regard to the ATLO T cell compartment, it was remarkable to observe that a substantial proportion of ATLO T cells were regulatory in nature, with abundant populations of two major T reg cell subsets. Given indications that Foxp3+ T reg cells are atheroprotective (16), it is tempting to suggest that ATLO T reg cells confer a benefit to the host, but the veracity of this idea remains to be determined. Furthermore, it will be important to determine if the disproportionate number of T reg cells in the adventitial infiltrates holds true in all adventitial leukocyte accumulations, including those more diffuse T cell infiltrates that occur before or without accompanying B cells. The surprisingly high percentage of T reg cells in ATLOs versus the more diffuse infiltrate in the thoracic aorta (10) suggests that both T reg cell subsets home into or proliferate within ATLOs subsequent to the formation of the diffuse T cell-dominated infiltrate of the thoracic aorta. It will also be important in future work to determine if the substantial recirculation of T cells into the adventitia compared with that of B cells in our adoptive transfer studies was limited to a large proportion of T reg cells or whether T reg cells particularly expanded in situ. Because the treatment of apoE-/- mice with LTbetaR-Ig greatly reduced HEV abundance, and because HEVs in turn mediate T cell recruitment into ATLOs, our data imply that continuous LTbetaR activation maintains a high rate of aorta T cell recirculation. Thus, manipulation of the LTbetaR pathway may be one means to regulate the accumulation of T cells, including T reg cells in diseased arteries.
###end p 48
###begin p 49
###xml 143 144 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 148 149 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 256 257 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 261 262 258 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 267 269 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 356 358 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 360 362 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 419 421 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 499 501 493 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
An unresolved issue requiring further investigation is the source of ligand to activate LTbetaR signaling in medial SMCs. The presence of CD11c+CD68+ cells in the media between ATLOs and atherosclerotic plaques led us to consider the possibility that CD11c+CD68+ Ly6Clo monocytes that accumulate in atherosclerotic plaques might be a source of the signal (45, 62). In agreement with this possibility, we found that Ly6Clo monocytes expressed higher levels of LTbeta compared with more classical Ly6Chi monocytes. Studies to manipulate LTbeta expression selectively in these monocytes would help to determine whether they serve as the source of activating signal in the induction of ATLOs through SMC activation.
###end p 49
###begin p 50
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 182 185 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 381 385 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 385 388 382 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 514 516 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 518 520 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 696 697 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 698 699 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 798 799 789 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 835 837 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 899 901 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 1124 1126 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 1128 1130 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib64">64</xref>
###xml 1873 1874 1864 1865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 1875 1876 1866 1867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
A major issue raised by our data relates to the functional impact of ATLOs on atherosclerosis. It is not surprising that the short treatment period of severely diseased and aged apoE-/- mice with LTbetaR-Ig failed to significantly reverse or aggravate the disease in standard atherosclerosis assays (unpublished data). To circumvent this limitation, it may be valuable to generate apoE-/- mice with tissue-selective deletion of the LTbetaR in SMCs or deletion of LTbeta in leukocytes subsets known to affect TLOs (32, 34). While these experiments are underway, our data encourage reexamination of the roles of immune cell subsets in advanced stages of atherosclerosis as opposed to early stages (1-6). As pointed out above, most studies in mice have focused on the early stages of atherosclerosis (6), when autoreactive T and B cells (63) may not yet have had the opportunity to be fully activated (61). That natural T reg cells and the CD137/CD137L pair (which are both implicated in the regulation of tolerance and autoimmunity) control the development of atherosclerosis was recently demonstrated in hyperlipidemic mice (16, 64), and here we have identified two T reg cell subsets in ATLOs. It is well established that autoimmune diseases develop in clinically separable phases and only in their late stages, when tolerance toward autoantigen(s) is breaking down, do they convert to explicit self-reactivity associated with debilitating tissue destruction. Similar multistage immune responses may occur in atherosclerosis. Clinically overt disease such as myocardial infarction is a late event triggered by plaque rupture and endothelial cell erosion. It will be of considerable interest to examine the possibility that these events are caused by autoreactive T- and/or B cells and/or autoantibodies, as well as dysfunction of T reg cells on the diseased arterial wall (1-6).
###end p 50
###begin p 51
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Finally, our data should help to advance experiments in aged apoE-/- mice to test the efficacy of pharmaceuticals that have been developed to treat autoimmune disorders. These pharmaceuticals range from clinically effective therapies for rheumatoid arthritis, including several anti-B cell-based pharmaceuticals to preclinical pharmaceuticals that target plasma cells or disrupt T-B cell help (50).
###end p 51
###begin title 52
MATERIALS AND METHODS
###end title 52
###begin title 53
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 53
###begin p 54
###xml 308 311 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 375 379 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 379 382 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 824 827 810 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 924 928 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ldlr</italic>
###xml 928 931 911 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 936 940 919 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 940 943 923 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1050 1052 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib65">65</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 76 80 <span type="species:ncbi:10090">Mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 468 473 <span type="species:ncbi:9606">human</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
Mice on the C57BL/6J background were purchased from The Jackson Laboratory. Mice were housed in a specific pathogen-free environment on a 12-h light/dark cycle and fed a standard rodent chow (Altromin). Animal procedures were approved by the Animal Care and Use Committee of Thuringia. Treatment of aged apoE-/- mice by soluble (decoy) LTbetaR-Igis was as follows: 75-wk-old apoE-/- mice were treated by 3 weekly i.p. injections of 75 mug LTbetaR-Ig or 75 mug control human serum IgG (Gamunex 10%; Bayer Vital) as control. 1 wk after the third application, animals were killed and aortae were dissected. The aorta was perfused in situ and care was taken to preserve the adventitia. For qRT-PCR and microarray analyses, aortae were dissected at 8degreesC without adherent adipose tissue. We found that treatment of young apoE-/- mice on a cholesterol diet by LTbetaR-Ig does not affect plasma lipids. Independent colonies of Ldlr-/- and apoE-/- mice were studied at the University of Chicago, and lipid levels were determined as previously described (65). These 8-wk-old mice were maintained on a high cholesterol (Western) diet for 12 wk in the absence or presence of LTbetaR-Ig.
###end p 54
###begin title 55
Morphometry, histology, and immunohistochemistry.
###end title 55
###begin p 56
###xml 300 310 293 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. renalis</italic>
###xml 565 566 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 568 570 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1170 1171 1157 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1173 1175 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 772 775 <span type="species:ncbi:12461?0.5579302587176603|species:ncbi:42005?0.03487064116985377|species:ncbi:63330?0.02249718785151856">HEV</span>
###xml 1290 1294 <span type="species:ncbi:10090">mice</span>
Tissues were embedded in Tissue Tec (Sakura Finetek) and stored at -80degreesC. 10-mum cross sections were prepared, and every 10th section was stained with Oil Red O/hematoxylin. Eight consecutive Oil Red O-stained sections of the aortic arch/innominate artery and the abdominal aorta distal to the A. renalis were used to quantify atherosclerosis and corresponding ATLO sizes. Tissue areas were determined using Leica Q500/W software. Elastic fibers were stained with Unna-Taenzer orcein stain. Fluorescence immunohistology was performed as previously described (9, 10), using marker antibodies CD68 (macrophages; Serotec, Ltd.), CD3epsilon (T lymphocytes; 145-2C11; BD), CD45R/B220 (B lymphocytes; BD), CD35/CD21b (CR1, FDCs; BD), MECA-79 (PNAd carbohydrate epitope in HEV; BD), MECA-32 (panendothelial cell antigen; BD), MAdCAM-1 (MECA-367; BD), Ki67 (M-19; Santa Cruz Biotechnology, Inc.), LYVE-1 (lymphatics; Acris), ER-TR7 (reticular fibroblasts; BMA), 8.1.1 (gp38, podoplanin; Acris), CD138 (syndecan-1; BD), CXCL13 (BLC; R&D Systems), CCL21 (SLC; R&D Systems), IgD (11-26c.2a; BD). DAPI was used to stain DNA. Secondary antibodies were as previously described (9, 10). FITC-labeled PNA (Vector Laboratories) was used to stain centrocytic B cells. TLOs in atherosclerotic aortae of mice were classified into developmental stages, as described in Fig. S1.
###end p 56
###begin title 57
Flow cytometry.
###end title 57
###begin p 58
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 358 359 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1559 1561 1544 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 1569 1571 1554 1556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1602 1603 1587 1588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1608 1609 1593 1594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1613 1615 1598 1600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1624 1626 1609 1611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1657 1658 1642 1643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1663 1664 1648 1649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1668 1670 1653 1655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 1295 1300 <span type="species:ncbi:10090">mouse</span>
Digests from similarly sized diseased portions of thoracic or abdominal aortae were prepared as previously described (11). After digestion, cell suspensions were filtered through a 70-mum cell strainer and centrifuged. Cell pellets were resuspended in PBS containing 2% FCS and pretreated with purified anti-mouse CD16/32 mAb at a concentration of 0.5 mug/106 cells for 10 min on ice to block Fc receptor binding. Without washing, cells were incubated with mAbs for 25 min at 4degreesC, washed twice, and, when required, incubated with secondary mAbs or streptavidin conjugates for an additional 20 min. After washing, samples were analyzed with a FACSCalibur or a FACSCantoII using CellQuest Pro or FACSDiva software (BD). The following mAbs were used: CD45-PE-Cy7 (clone 30-F11), TCRbeta-FITC or -Biotin (H57-597), CD4-PE or -APC (GK1.5), CD8alpha-Pacific blue (53-6.7), CD28-Biotin (37.51), CD69-PE (H1.2F3), CD44-APC (1M7), CD16/32 purified (93), and CD115-Biotin (AFS98; all from eBioscience); CD19-APC (1D3), CD11b-FITC (M1/70), CD25-FITC (7D4), NK1.1-FITC (PK136), Gr-1-APC (RB6-8C5, reacts with Ly-6C), appropriate IgG isotype controls, and Streptavidin-PerCP-Cy5.5 or -PerCP (all from BD); and F4/80-FITC (CI:A3-1; AbD Serotec). Intracellular Foxp3 staining was performed with the anti-mouse-Foxp3-PE (FJK-16s) staining kit (eBioscience) according to the manufacturer's instructions. Monocyte subsets were purified with a FACSAria cell sorter (BD) based on forward and sideward characteristics and marker antigen expression, as previously described (45). Ly-6Chi monocytes were sorted as CD115+F4/80+Gr-1hi and Ly6Clo monocytes were sorted as CD115+F4/80+Gr-1lo.
###end p 58
###begin title 59
SMC purification.
###end title 59
###begin p 60
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib66">66</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
SMCs were obtained from aortae of C57BL/6 mice by sequential dissection, careful removal of adventitial tissue and endothelial cells, and collagenase/elastase (Worthington Biochemical Corporation; Sigma-Aldrich) digestion (66). Purity of SMCs was >/=99%, as shown by alpha-SMA positivity of cytospins.
###end p 60
###begin title 61
Tracer analyses.
###end title 61
###begin p 62
Fluorescein-conjugated, lysine-fixable dextrans (Invitrogen) were injected i.v. in 200 mul at 5 mg/ml (10 kD) and 2 mg/ml (500 kD). 15 min later, aorta, LNs, and spleen were removed and fixed for 3 h in 4% paraformaldehyde in PBS. Tissues were washed in PBS and incubated overnight at 4degreesC in 20% sucrose/PBS before freezing in Tissue-Tek (Sakura Finetek).
###end p 62
###begin title 63
qRT-PCR.
###end title 63
###begin p 64
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb</italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltb</italic>
###xml 496 500 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ltbr</italic>
###xml 567 575 567 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf14</italic>
###xml 646 654 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf1a</italic>
###xml 725 733 725 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf1b</italic>
###xml 804 809 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccl21</italic>
###xml 876 882 876 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl13</italic>
###xml 953 960 953 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
###xml 1031 1035 1031 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Il7r</italic>
###xml 1106 1112 1106 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ELISA.</italic>
RNAs were extracted with Trizol (Invitrogen) and purified using RNeasy Micro kit (QIAGEN). RNA integrity was determined on RNA 6000 Nano LabChips (Agilent Technologies). qRT-PCR was performed as previously described (10). Specificity of primers was confirmed by melting curve analyses and product sequencing. Forward and reverse primers were as follows Actb, 5'-GCTCCATCCTGGCCTCACTGT-3', 3'-GAAAGGGTGTAAAACGCAGCTCA-5' (136 bp); Ltb, 5'-GAGACAGTCACACCTGTTG-3'; 3'-CCTGTAGTCCACCATGTCG-5' (141 bp); Ltbr, 5'-TGGTGCTCATCCCTACCTTC-3', 3'-TCCCAAACTCTCCTCCACAC-5' (181 bp); Tnfrsf14, 5'-TCCATCCTTTTGCCACTTGTGA-3', 3'-CTGTCTCCTCCTCGGTCTCAGC-5' (181 bp); Tnfrsf1a, 5'-CGATAAAGCCACACCCACAACC-3', 3'-TGGTACATCTCCCTGCCACTCA-5' (223 bp); Tnfrsf1b, 5'-GGCAGAGGAGCCTAGTTGTTGC-3', 3'-ATCCACACAAGCACAGGAGCTG-5' (238 bp); Ccl21, 5'-ATCCCGGCAATCCTGTTCTT-3', 3'-AGTTCTCTTGCAGCCCTTGG-5' (201 bp); Cxcl13, 5'-TCCTGGGAAGCTGGTGCAATG-3', 3'-TCATCAGGGTCACAGTGCAAAGG-5' (216 bp); Glycam1, 5'-CCAAGTCAAGCCAGACAGTGGA-3', 3'-GCAGACTGAGAGGTGGTGGTCA-5' (196 bp); Il7r, 5'-TGCGCACACCACAATGAGTGC-3', 3'-TGACCGGACAGACACTCCAATCC-5' (247 bp). ELISA. CXCL13 ELISA was performed as recommended by the supplier (R&D Systems).
###end p 64
###begin title 65
Cell culture.
###end title 65
###begin p 66
###xml 189 191 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib67">67</xref>
###xml 149 152 <span type="species:ncbi:10116">rat</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
SMCs were maintained in DMEM/F12/10% FCS (Invitrogen) and used at passages 1-3. For qRT-PCR analyses, cells were stimulated with 10 mug/ml agonistic rat anti-mouse alpha-LTbetaR mAb 5G11b (67) or 1 ng/ml mouse recombinant TNF (R&D Systems) as indicated in the figure legends.
###end p 66
###begin title 67
Microarray analysis.
###end title 67
###begin p 68
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib68">68</xref>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib69">69</xref>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib70">70</xref>
###xml 857 861 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 861 864 857 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1004 1006 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib71">71</xref>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 538 543 <span type="species:ncbi:10090">mouse</span>
Aorta microarray analyses were performed as previously reported (68, 69). 3 wild-type and apoE-/- mice each at 6, 32, and 78 wk or LCM-derived aorta tissues at 78 wk were used. Signal intensities were calculated from the raw data and scaled to an array trimmed mean of 500. All further steps were performed using R and Bioconductor. Logarithmized signals were normalized across arrays using quantile normalization (70), and data were filtered before statistical analysis to remove genes with low expression or without variability between mouse groups at 6 and 78 wk. Probe sets were included if in one group a minimum of 2 arrays was called present (detection P </= 0.05) and 2 or 3 arrays showed a log signal >/=log2(200). Recorded genes were required to be up-regulated from 6-78 wk with a fold change of at least log2(2.5). Using the data from the three apoE-/- groups, the resulting list was subjected to a one-factor analysis of variance with Benjamini and Hochberg correction for multiple testing (71). 1,163 probe sets were significantly differentially expressed (P </= 0.05) and used for further analyses (Table S1).
###end p 68
###begin title 69
Cluster analysis.
###end title 69
###begin p 70
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib72">72</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib73">73</xref>
###xml 607 615 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 760 768 760 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 a</xref>
###xml 1217 1223 1217 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 1879 1885 1879 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
Group means of the selected probe sets were standardized to zero mean and unit variance (72). A fuzzy c-means algorithm was applied with the euclidean metric and fuzzy parameter FP = 1.2. Using the maximum-membership function, hard cluster assignments were identified for the best out of 30 runs of the fuzzy c-means algorithm with random initial partitions (73). Data were used to exploit the different time windows of atherosclerosis formation and ATLO development. For this purpose, each probe set of a presumed atherosclerosis cluster was required to show significant up-regulation between 6 and 32 wk (Fig. 4 a, Table S1, and Fig. S4), whereas each probe set of a presumed ATLO cluster was required to show significant up-regulation between 32 and 78 wk (Fig. 4 a, Table S1, and Fig. S4 B). This approach ascertained that genes that were up-regulated between 6 and 32 wk were segregated from genes that were newly appearing during the time window 32 to 78 wk. GO molecular function terms in both clusters confirmed the marked expression of macrophage/inflammation genes in the atherosclerosis cluster whereas the ATLO cluster showed preferential expression of B cell immunity and adaptive immune-effector genes (Fig. 4 and Table S1). Although many genes in each cluster have multiple biological functions depending on their tissue-specific expression and local biology, these data provide preliminary evidence that the atherosclerosis cluster contained genes that largely represent the influx of blood-derived monocytes into the arterial wall intima, including multiple inflammation-regulating genes, whereas the ATLO cluster contained genes known to regulate embryonic LN development and TLO formation with a major overrepresentation component of genes regulating B cell maturation, GC formation, plasma cells (immunoglobulin genes), autoimmunity, and affinity maturation (Fig. 4). Selected transcripts were confirmed by quantitative RT-PCR (Fig. S5).
###end p 70
###begin title 71
LCM procedure.
###end title 71
###begin p 72
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib74">74</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib76">76</xref>
###xml 923 926 915 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 919 926 911 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE<sup>&#8722;/&#8722;</sup></italic>
###xml 927 931 <span type="species:ncbi:10090">mice</span>
LCM was performed using a Palm MicroBeam laser system (PALM Microlaser Technologies AG) according to published procedures (74-76) with slight modifications. 10 sections (10 mum) of the abdominal aorta were placed on cooled PEN membrane-covered glass slides (PALM Industries). Slides were dried 10 min at 45degreesC and stored in an exsiccator. Approximately 200 unstained sections for each arterial wall compartment/array were obtained. Each section was collected from the membrane and transferred to Trizol (Invitrogen). RNA was extracted and purified using RNeasy Micro kit (QIAGEN). As a first step to ascertain reproducibility, RNA integrity, validity, and reliability of our LCM protocol, we established protocols to obtain various aorta arterial wall compartments. Unstained phase contrast images of 10 mum serial fresh-frozen tissue sections showed that the media/adventitia border (and for diseased arteries in apoE-/- mice, the media/atherosclerotic intima lesion border) could be readily identified before immunohistochemical staining caused by contrast-rich elastin fibers in the media. This allowed us to omit immunofluorescence staining before LCM. These data provide comprehensive information on media SMC gene expression of constitutively expressed genes (GEO accession no. ).
###end p 72
###begin title 73
Adoptive transfer experiments.
###end title 73
###begin p 74
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 432 433 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 506 510 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 510 513 509 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 774 775 773 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
Lymphocyte recirculation assays were done as previously described, with minor modifications (19). In brief, total splenocytes were isolated from 12-wk-old male C57BL/6J mice, and erythrocytes were treated with lysis buffer (QIAGEN). Cells were labeled with 5 muM CFSE (carboxyfluorescein diacetate succinimidyl ester) for 10 min at room temperature according to the manufacturer's protocol (Invitrogen). After washing, up to 35 x 106 CFSE-labeled cells were injected into the tail vein of 40- or 90-wk-old apoE-/- mice. 3 or 18 h after cell transfer, recipient mice were killed and whole aorta with adjacent LNs (i.e., renal, caudal, lumbar, and inguinal LNs) were cryo-preserved. Sections were analyzed by confocal laser scanning microscopy at 18 h when > 90% of blood CFSE+ cells had left the circulation. To reduce unspecific autofluorescence of lipid deposits of the plaque region, LSM510 software was used. For this purpose two laser lines were applied separately to the same specimen. The first laser (488 nm) detected CFSE-specific signals as well as autofluorescence, and the second unrelated laser (543 nm) was used to visualize unspecific autofluorescence.
###end p 74
###begin title 75
In situ hybridization.
###end title 75
###begin p 76
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib77">77</xref>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccl21a</italic>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycam1</italic>
In situ hybridization was performed on cryostat tissue sections as previously described (77), with slight modifications. In brief, cDNA fragments were amplified using the primers 5'-ATCCCGGCAATCCTGTTCTT-3', 5'-AGTTCTCTTGCAGCCCTTGG-3' (Ccl21a) and 5'-CCAAGTCAAGCCAGACAGTGGA-3', 5'-GCAGACTGAGAGGTGGTGGTCA-3' (Glycam1) and cloned using the TOPO Cloning kit (Invitrogen). Digoxigenin (Roche) labeled cRNAs were applied to each section and hybridized at 65degreesC overnight. Tissue sections were rinsed as described in the Supplemental text (available at ). For color reaction, slides were incubated with BM-Purpel/Levamisol/Tween.
###end p 76
###begin title 77
Statistical analyses.
###end title 77
###begin p 78
###xml 39 40 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 110 111 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Measurements are expressed as means of n samples +/- SEM. Data were analyzed by two-tailed unpaired Student's t test, Pearson correlation, and Chi-Square test, as stated in figure legends using SPSS software (SPSS).
###end p 78
###begin title 79
Online supplemental material.
###end title 79
###begin p 80
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">early</italic>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">late</italic>
###xml 431 435 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 435 438 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 794 798 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 798 801 795 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 837 841 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 841 844 838 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1175 1179 1172 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apoE</italic>
###xml 1179 1182 1176 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 1183 1187 <span type="species:ncbi:10090">mice</span>
###xml 1209 1214 <span type="species:ncbi:10090">mouse</span>
Fig. S1 shows ATLO stage classification. Fig. S2 shows that ATLOs are distinguished from paraaortic LNs by shape, structure, and location. Fig. S3 and Video 1 show that transferred CFSE+ splenocytes are associated with HEVs, but not with blood vessel lumina. Fig. S4 shows early atherosclerosis cluster versus late ATLO cluster. Fig. S5 shows qRT-PCR of selected genes of the adaptive immune response in 32 and 78 wk wild-type and apoE-/- aortae. Fig. S6 is an overview of ATLO conduit structure revealed by ER-TR7. Fig. S7 and Video 2 show that conduits connect the media SMC compartments with various ATLO structures. Fig. S8 and Video 3 show that conduits access HEVs. Fig. S9 shows extended LTbetaR-Ig treatment does not affect total plasma cholesterol or lipoprotein-cholesterol levels in apoE-/- mice. Table S1 lists probe sets of apoE-/- aorta up-regulated between 6 and 32 wk for atherosclerosis cluster and ATLO cluster. Table S2 shows LCM-derived ATLO and atherosclerosis lesion gene expression. Table S3 shows marker genes and Tnfr family member genes in LCM microarrays of wild-type abdominal aorta media and adventitia. Table S4 shows serum lipid values in aged apoE-/- mice maintained on normal mouse chow treated with LTssR-Ig or control hu-IgG. There is also supplemental text. Online supplemental material is available at .
###end p 80
###begin p 81
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
We thank G. Weber, M. Voigt, and S. Nossmann for mouse preparations and morphometry; C. Strohl for microarray analyses; M. Franke for qRT-PCR analyses; B. Lemser for Western blots, SMC cultures, and mouse dissection; K. Bonhagen for help with cell sorting; N. John and B. Kaiser for mouse dissection and CXCL13 ELISA; and A. Kirsch for art work.
###end p 81
###begin p 82
This work was supported by the German Research Organization (HA 1083/15-1/HA1083/13-3; LO1467/1-1 WE2224/5) to A.J.R. Habenicht, K. Lotzer, D. Hu, and F. Weih; by the German BMBF (grant 031270D) to D. Radke; by the Netherlands Organization for Scientific Research (grant 918.56.612) to R.E. Mebius; and the National Institutes of Health (grant 1 RO1HL085516) to G.S. Getz.
###end p 82
###begin p 83
The authors declare that they have no competing financial interests.
###end p 83

